Picture of Idorsia logo

IDIA — Idorsia News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Idorsia And Viatris Enter Into Significant Global Research And Development Collaboration

Feb 28 (Reuters) - Idorsia Ltd  IDIA.S :
    * IDORSIA AND VIATRIS ENTER INTO A SIGNIFICANT GLOBAL
RESEARCH AND
DEVELOPMENT COLLABORATION
    * COLLABORATION WITH VIATRIS INC FOR AN UPFRONT PAYMENT OF
USD 350
MILLION
    * VIATRIS WILL HAVE WORLDWIDE COMMERCIALIZATION RIGHTS FOR
BOTH
SELATOGREL AND CENERIMOD
    * IDORSIA HAS ALSO GRANTED VIATRIS A RIGHT OF FIRST REFUSAL
AND
FIRST NEGOTIATION FOR CERTAIN OTHER PIPELINE ASSETS.

Source text for Eikon:  ID:nGNX7drRWp 
Further company coverage:  IDIA.S 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Idorsia

See all news